How it started
History
Alembic Chemical Works Company Ltd. was established in 1907 in Vadodara, Gujarat, initially producing tinctures and alcohol. It later diversified into cough syrups, vitamins, tonics, and sulphur drugs. In the 1960s, the company began producing penicillin, with its plant inaugurated in 1961 by then Prime Minister Lal Bahadur Shastri. Bulk production of vitamin B12 and erythromycin started in 1971. In 1999, the company changed its name from Alembic Chemical Works Company Ltd. to Alembic Ltd.
In 2007, Alembic Ltd. acquired the non-oncology formulation business of Dabur Pharma Ltd for ₹159 crore.
In 2010, Alembic Pharmaceuticals was formed after a demerger from Alembic Ltd. The demerger was carried out through the allotment of 133,515,914 equity shares of ₹2 each to Alembic Ltd. shareholders, reducing Alembic Ltd.’s stake to 29.18%. Shares of Alembic Pharmaceuticals were listed on the Bombay Stock Exchange and National Stock Exchange on 20 September 2011, following the demerger.
In 2014, Alembic Pharmaceuticals formed a joint venture with Adwiya Mami SARL to enter Algeria. In 2017, the company acquired Orit Laboratories LLC. USA. In 2019, it entered the Chinese market through a joint venture.
In 2022, Alembic Pharmaceuticals acquired 100% stake in Aleor Dermaceuticals Ltd. and merged it with the company. In 2025, the U.S. subsidiary of Alembic Pharmaceuticals acquired Utility Therapeutics Ltd, which produces the urinary tract infection drug Pivya (pivmecillinam 185 mg), for US$12 million.
From Wikipedia’s article on Alembic Pharmaceuticals Ltd, shared under CC BY-SA 4.0.2